Retrospective Study
Copyright ©The Author(s) 2024.
World J Diabetes. Jan 15, 2024; 15(1): 43-52
Published online Jan 15, 2024. doi: 10.4239/wjd.v15.i1.43
Figure 1
Figure 1 Nomogram prediction model for diabetic nephropathy in patients with type 2 diabetes mellitus. Scr: Serum creatinine; HbAlc: Glycosylated hemoglobin; DR: Diabetic retinopathy; FBG: Fasting blood glucose.
Figure 2
Figure 2 Decision tree model of diabetic nephropathy in patients type 2 diabetes. Scr: Serum creatinine; HbAlc: Glycosylated hemoglobin; FBG: Fasting blood glucose.
Figure 3
Figure 3 Random forest model of diabetic nephropathy in patients with type 2 diabetes. Scr: Serum creatinine; HbAlc: Glycosylated hemoglobin; DR: Diabetic retinopathy; FBG: Fasting blood glucose.
Figure 4
Figure 4 Receiver operating characteristic curves for the validation sets of the three models. A: Nomogram; B: Decision-making tree; C: Random forest. AUC: Area under the receiver operating characteristic curve; CI: Confidence interval.